YANGAROO and the NAACP enter into multi-year agreement for the NAACP Image Awards
TORONTO, Aug. 25, 2020 (GLOBE NEWSWIRE) — YANGAROO Inc. (TSX-V: YOO, OTC: YOOIF, the “Company”), the software leader in workflow […]
Sterling National Bank Partners with IPsoft’s Amelia®–Most Human AI™–to Launch Cognitive Customer Service Agent “Skye”
~Skye will use Natural Language Understanding and Artificial Intelligence to automate 3 million contact center inquiries per year~NEW YORK and […]
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) — EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”), an emerging [...]
Algernon to Provide Update on its Ifenprodil IPF and Chronic Cough Phase 2 Human Study Featured on BioPub Webcast Hosted by Dr. KSS MD PhD
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or […]
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
NEW YORK, Aug. 25, 2020 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines […]
Altair Joins Avicenna Alliance to Support Simulation-based Development of Medical Breakthroughs
TROY, Mich., Aug. 25, 2020 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global technology company providing solutions in product development, […]
ContraFect Announces Funding Agreement with the Cystic Fibrosis Foundation
YONKERS, New York, Aug. 25, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery […]
Immunovant Announces Positive Topline Results from Multi-Center, Placebo-Controlled Phase 2a Trial of IMVT-1401, A Novel Investigational Anti-FcRn Antibody Delivered by Subcutaneous Injection, in Myasthenia Gravis
3.8-point mean improvement on the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale was statistically significant vs. placebo (p = […]
AlloVir to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) — AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, will present […]
TSX News -
Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®
MONTREAL and BOCA RATON, Fla, Aug. 25, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) and TherapeuticsMD, Inc. […]
